From: A three-country comparison of psychotropic medication prevalence in youth
 | US (n = 127,157) | Netherlands (n = 110,944) | Germany (n = 356,520) | ||||||
---|---|---|---|---|---|---|---|---|---|
Age(yr) | Male | Female | Total* | Male | Female | Total* | Male | Female | Total* |
0–4 | 1.21 | 0.52 | 0.88 | 1.00 | 0.71 | 0.86 | 1.86 | 1.38 | 1.63 |
 | 1.10–1.34 | 0.45–0.61 | 0.87–0.88 | 0.84–1.18 | 0.58–0.87 | 0.85–0.87 | 1.73–2.00 | 1.26–1.51 | 1.62–1.63 |
5–9 | 11.95 | 4.38 | 8.25 | 3.99 | 1.30 | 2.68 | 2.85 | 1.19 | 2.04 |
 | 11.39–12.52 | 4.03–4.75 | 8.25–8.26 | 3.66–4.33 | 1.11–1.52 | 2.67–2.69 | 2.69–3.00 | 1.09–1.30 | 2.04–2.04 |
10–14 | 14.16 | 5.97 | 10.17 | 5.38 | 1.95 | 3.71 | 3.37 | 1.33 | 2.38 |
 | 13.48–14.87 | 5.5–6.46 | 10.16–10.18 | 5.00–5.78 | 1.72–2.2 | 3.70–3.72 | 3.22–3.53 | 1.23–1.44 | 2.37–2.38 |
15–19 | 7.62 | 6.30 | 6.98 | 4.35 | 4.44 | 4.40 | 1.75 | 2.12 | 1.93 |
 | 7.01–8.26 | 5.82–6.82 | 6.97–6.99 | 4.04–4.68 | 4.12–4.78 | 4.39–4.40 | 1.63–1.87 | 1.99–2.26 | 1.93–1.93 |
Total* | 8.87 | 4.35 | 6.66 | 3.72 | 2.11 | 2.94 | 2.47 | 1.50 | 2.00 |
 | 8.86–8.87 | 4.34–4.35 | 6.66–6.67 | 3.72–3.73 | 2.11–2.12 | 2.94–2.94 | 2.47–2.47 | 1.5–1.51 | 2.00–2.00 |